BMJ  2007;335:253-257 (4 August), doi:10.1136/bmj.39255.692222.AE

Clinical Review

Management of asthma in children

Paediatric Respiratory Unit, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP

The first 150 words of the full text of this article appear below.

Inhaled corticosteroids, although safe if given at the recommended dose, can have important adverse effects if given above it, including adrenal suppression Long acting 2 antagonists can be used as add-on treatment to avoid further increases in the dose of inhaled corticosteroid but can be associated with increased risk of exacerbations and hospital admission Long acting 2 antagonists should therefore be continued only if a demonstrable response to treatment occurs Inhaled corticosteroids do not prevent the development of asthma Low dose inhaled corticosteroid should not be used as preventive treatment for episodic viral wheeze Referral to a specialist centre should be considered when a child reaches step 4 of the British Thoracic Society/Scottish Intercollegiate Guidelines Network guideline or earlier, depending on the expertise of the general practitioner and the resources available

This review on childhood asthma focuses on acute and chronic management in relation to the asthma phenotypes reviewed in our previous . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Diagnosis of asthma in children

J Townshend, S Hails, and M Mckean
BMJ 2007 335: 198-202. [Extract] [Full Text] [PDF]

Lesson of the week: Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate • Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult

A J Drake, R J Howells, J P H Shield, A Prendiville, P S Ward, E C Crowne, and Peter Hindmarsh
BMJ 2002 324: 1081-1083. [Extract] [Full Text] [PDF]

Asthma drug delivery devices for children

Christopher O'Callaghan and Peter W Barry
BMJ 2000 320: 664. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Zuidgeest, M. G. P., van Dijk, L., Spreeuwenberg, P., Smit, H. A., Brunekreef, B., Arets, H. G. M., Bracke, M., Leufkens, H. G. M. (2009). What Drives Prescribing of Asthma Medication to Children? A Multilevel Population-Based Study. Ann Fam Med 7: 32-40 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

A correction is required in this article

E.S. Prakash
bmj.com, 8 Aug 2007 [Full text]

Long acting beta-2 agonists and not antagonists

Gerald CH Koh, et al.
bmj.com, 8 Aug 2007 [Full text]

Allergy in children forgotten again !

harry morrow brown
bmj.com, 6 Aug 2007 [Full text]

TYPO ?

SIMON BIRCH
bmj.com, 8 Aug 2007 [Full text]

Corrections

Tim Lancaster
bmj.com, 8 Aug 2007 [Full text]

Untreatable asthma could be latent tetany in young infants, so get ionized Ca2+ investigated.

Kishan Kumar Jani, et al.
bmj.com, 12 Aug 2007 [Full text]

Corticosteroids for episodic viral wheeze

Israel Amirav, et al.
bmj.com, 13 Aug 2007 [Full text]

Correction published

Sharon Davies
bmj.com, 17 Aug 2007 [Full text]

Online poll

Find out more here>> and here>>